Last reviewed · How we verify
NCT03561506
Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty
Phase 4 trial testing Ferric carboxymaltose in Postoperative Anemia in 80 participants. Status unknown.
11 June 2019
Quick facts
| Lead sponsor | The Catholic University of Korea |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 11 June 2018 |
| Primary completion | 11 June 2019 |
| Estimated completion | 11 December 2019 |
Drugs / interventions tested
- Ferric carboxymaltose (FERRIC CARBOXYMALTOSE) — full drug profile →
- 0.9% Normal Saline
Conditions studied
- Postoperative Anemia — all drugs for Postoperative Anemia →
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
- Total Knee Arthroplasty — all drugs for Total Knee Arthroplasty →
Sponsor
The Catholic University of Korea
Who can join
19 and older, any sex, with Postoperative Anemia or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this study is to evaluate the safety and efficacy of preoperative intravenous ferric carboxymaltose in patients with anemia undergoing Simultaneous Bilateral Total knee replacement in terms of Quality of life (QOL) and objective measures (Hb and Iron parameters).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03561506
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ferric carboxymaltose
Trials testing the same drug.
- NCT07057973 — The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly · NA · recruiting
- NCT05744219 — Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial · Phase 3 · recruiting
- NCT06080893 — The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures · Phase 4 · completed
- NCT05545527 — Neuroimaging Ancillary Study · completed
- NCT04968379 — Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia · Phase 2 · withdrawn
Other The Catholic University of Korea trials
Trials by the same sponsor.
- NCT06367998 — Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair · Phase 4 · not yet recruiting
- NCT07174544 — Mobile Self-Management Program for Stress Reduction in Young Adults · NA · completed
- NCT05671705 — Effect of Sarcopenia in Stroke Patients · completed
- NCT05509244 — Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery · NA · unknown
- NCT05539690 — Effect of Balance Training on White Matter Tracts in Healthy Elderly Population · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03561506 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Catholic University of Korea
- Last refreshed: 19 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03561506.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing